Research and Markets Study this Comprehensive Analytical Review of All Aspects of the Oncology Field



HEAD Research and Markets Study this Comprehensive Analytical Review of All Aspects of the Oncology Field nbspnbsp nbspnbsp Research and Markets Study this Comprehensive Analytical Review of All Aspects of the Oncology Field Research and Markets researchandmarketscomreportsc14937 has announced the addition of Future Oncology to their offering Research and Markets httpwwwresearchandmarketscomreportsc14937 has announced the addition of Future Oncology to their offering Future Oncology is a comprehensive analytical review of all aspects of the oncology field for executives researchers and market analysts in the pharmaceutical biotechnology financial hospital and other health care related sectors It provides comprehensive uptodate analysis of scientific technological clinical and commercial developments in oncology To date Future Oncology has presented comprehensive information on all major malignancies covering over 1000 oncology drugs in development by developeraffiliate mechanism of action indication and status as well as numerous other related products and profiled hundreds of developers worldwide For every cancer indication the publication presents extensive global epidemiology incidence and mortality and USA epidemiology by gender age disease stage and survival by stage In addition descriptions of targets with utility as diagnostic prognostic or therapeutic applications in vitro and in vivo diagnostics in development or on the market and protocolsresults from monotherapy and combination trials of approved agents and those in development are presented as well estimated treatment costs Future Oncology is published as 12 issues several double issues per subscription period with a free index listing companiesinstitutions and subjects covered Example of some topics covered in this publication include Pancreatic Cancer Angiogenesis InhibitorsAntimetastatic Agents And Targeted DeliveryGene Transfer Approaches Endothelial Monocyteactivating Protein II IMAPII Vascular Endothelial Growth Factor VEGF Inhibitors Urokinase Plasminogen Activator uPA System Inhibitors Other Antiangiogenesis Agents Targeted Drug Delivery Targeted Toxins Radioimmunoconjugates Targeted Cytotoxics Gene Transfer Oncolytic Viruses For more information visit httpwwwresearchandmarketscomreportsc14937 Laura Wood Senior Manager Research and Markets email protected from spam bots Fax +353 1 4100 980



Research and Markets Study this Comprehensive Analytical Review of All Aspects of the Oncology Field